• Treatment Area:

    Parkinson's Disease

  • Study Aim:

    To advance our understanding of Parkinson’s Disease and accelerate the development of advanced therapies to improve outcomes for patients.

  • Recruitment Target:

    Ongoing patient recruitment of patient's diagnosed with Parkinson's Disease.

See Study Details Right Arrow
  • Treatment Area:

    Multiple Sclerosis

  • Study Aim:

    To discover whether the genes that contribute to MS risk are the same or different for people of non-European ancestry, with a focus on people from African & South Asian backgrounds.

  • Recruitment Target:

    400 patients

See Study Details Right Arrow
  • Treatment Area:

    Respiratory Syncytial Virus (RSV)

  • Trial Site Locations:
    Fylde Coast Clinical Research Blackpool, Royal Devon University Healthcare NHS Foundation Trust, Royal Free Hospital London
  • Study Aim:

    To evaluate the safety and immune response of an investigational vaccine (mRNA-1345) aimed at preventing RSV infection in high risk adults

  • Recruitment Target:

    100 patients

See Study Details Right Arrow
  • Treatment Area:

    Parkinson's Disease

  • Trial Site Locations:
    Newcastle University, Campus for Ageing and Vitality.
  • Study Aim:

    This study, run by The Michael J. Fox Foundation for Parkinson’s Research, is exploring the link between loss of smell and brain disease by providing study participants with a simple scratch-and-sniff test.

  • Recruitment Target:

    15,000 patients without Parkinson's Disease.

See Study Details Right Arrow
  • Treatment Area:

    Alopecia Areata

  • Trial Site Locations:
    Queen Anne Street Medical Centre, London
  • Study Aim:

    To assess the safety, efficacy & dose response characterisation of STSO1 (Dithranol/ProSilic) administered topically, once daily, to affected scalp areas for 6 months, in patients who have mild to moderate Alopecia Areata.

  • Recruitment Target:

    100 patients with mild to moderate Alopecia

See Study Details Right Arrow
  • Treatment Area:

    Chronic Kidney Disease and Pruritus

  • Trial Site Locations:
    The Royal London Hospital, Hull University Teaching Hospital, Newcastle Hospitals NHS Foundation Trust, Nottingham University Teaching Hospital, Churchill Hospital, Oxford University
  • Study Aim:

    To evaluate the efficacy and safety of MC2-25 Cream and MC2-25 vehicle in subjects with chronic kidney disease-associated pruritus (CKD aP)

  • Recruitment Target:

    22 Patients: Non-Dialysis CKD stage 3

    22 Patients: Non-dialysis CKD stage 4/5

    Total: 44 Patients

See Study Details Right Arrow
  • Treatment Area:

    Asthma

  • Trial Site Locations:
    Queen Anne Street Medical Centre London, Egin Research High Wycombe, Royal Liverpool University Hospital
  • Study Aim:

    To understand the safety and efficacy of the drug AZD1402 in adults with moderate asthma, who regularly use inhaled corticosteroids (ICS) and long-acting beta-agonists (LABAs)

  • Recruitment Target:

    30 patients

See Study Details Right Arrow